Brief: X4 Pharma Announces Abstract Of Phase 3 Data To be Presented At 2023 Annual Meeting Of The Clinical Immunology Society

X4 Pharmaceuticals

12/04/2023 14:14

April 12 (Reuters) - X4 Pharmaceuticals Inc  XFOR.O :
    * X4 PHARMACEUTICALS ANNOUNCES LATE-BREAKING ABSTRACT OF
WHIM
PHASE 3 CLINICAL DATA ACCEPTED FOR ORAL PRESENTATION AT THE 2023
ANNUAL MEETING OF THE CLINICAL IMMUNOLOGY SOCIETY (CIS)

Source text for Eikon:  ID:nGNXJmySw 
Further company coverage:  XFOR.O 

 ((Reuters.Briefs@thomsonreuters.com;))